Subcellular post-transcriptional targeting: delivery of an intracellular protein to the extracellular leaflet of the plasma membrane using a glycosyl-phosphatidyl inositol (GPI) membrane anchor in neurons and polarised epithelial cells
O. Brown et al., Subcellular post-transcriptional targeting: delivery of an intracellular protein to the extracellular leaflet of the plasma membrane using a glycosyl-phosphatidyl inositol (GPI) membrane anchor in neurons and polarised epithelial cells, GENE THER, 7(22), 2000, pp. 1947-1953
The effectiveness of viral vector-mediated gene transfer depends on the exp
ression of therapeutic transgenes in the correct target cell types. So far,
however, little attention has been given to targeted subcellular distribut
ion of expressed transgenes. Targeting individual transgenes to particular
subcellular compartments will provide various advantages in increasing the
safety, efficacy, and specificity of viral vector-mediated gene delivery. V
iruses normally hijack the cellular protein synthesis machinery for their o
wn advantages. It is thus unknown whether cells infected with viral vectors
will be able to target proteins to the correct subcellular organelles, or
whether the subcellular targeting machinery would be selectively disrupted
by viral infection. In this article we explored whether a herpes simplex vi
rus type I-derived vector could be used to deliver a transgene engineered t
o be targeted to the extracellular membrane of target cells. To do so we co
nstructed a temperature-sensitive mutant HSV-1 vector, tsK-TT21 expressing
a recombinant marker protein, tissue inhibitor of metalloproteinases (TIMP)
, linked to sequence encoding a signal for the addition of a glycosylphosph
atidylinositol (GPI)-anchor within the endoplasmic reticulum. Our results d
emonstrate that HSV1-derived viral vectors can be used to target transgenes
as GPI anchored proteins to the outside leaflet of plasma membranes, witho
ut disrupting the targeting machinery of host epithelial cells or neurons.
This approach could then be used to target specific proteins to the cell me
mbrane to modify cell-cell interactions, the function of specific plasma me
mbrane proteins, or their interactions with other membrane proteins, and al
so to target a prodrug converting enzyme to the plasma membrane of target c
ells, therefore enhancing its cell killing effects.